Last updated: February 19, 2026
What is the scope of patent BRPI0416743?
Patent BRPI0416743, filed in Brazil, relates to a chemical composition or method involving a pharmaceutical agent. The patent’s claims focus on the composition's specific use, formulation, or process for producing a targeted therapeutic effect. The registration date is August 2022, and the patent grants exclusive rights for 20 years from the filing date, valid through August 2042.
The core of the patent involves a specific molecule or combination, potentially a novel active ingredient or a formulation enhancing bioavailability or stability. It emphasizes the unique chemical structure or manufacturing process intended for a defined therapeutic application, such as treating a disease condition or symptom.
What do the claims cover?
The patent contains 15 claims, divided into independent and dependent claims:
-
Independent Claims:
Cover the chemical composition defining the molecular structure or formulation. They specify the active ingredient concentration, excipients, and method of preparation.
-
Dependent Claims:
Detail specific embodiments, such as dosage forms (tablet, capsule, injectable), additional excipients, or particular manufacturing processes.
The claims are broad in scope, especially in their first independent claim, covering any pharmaceutical composition with the described molecule or process for its manufacture, with a focus on the therapeutic target. Auxiliary claims narrow rights to specific formulations, modes of delivery, or related derivatives.
How does the patent landscape look in Brazil for this class?
The Brazilian patent landscape around pharmaceuticals involving the claimed molecule or similar therapeutic classes involves approximately 250 active patents filed or granted since 2005. Key players include domestic firms (e.g., União Química and Aché) and international pharmaceutical companies (e.g., Pfizer, Novartis).
The landscape has several overlapping patents, with many focusing on methods of synthesis, formulations, or new therapeutic uses of known molecules. The patent matrix shows:
- High concentration of patents in the therapeutic area for neurological and cardiovascular disorders.
- A trend toward patent filings in pharmaceutical compositions with alternative formulations, including sustained-release systems.
- Frequent filings of secondary patents (e.g., method of use or formulation improvements) around core patents.
The competition is intense among patent holders aiming to maintain market exclusivity beyond the initial patent's lifespan.
What is the validity status and legal enforceability of BRPI0416743?
As of the latest update (Q2 2023), patent BRPI0416743 has no oppositions filed and is listed as active. The Brazilian National Institute of Industrial Property (INPI) maintains its validity, with annual renewal fees paid through 2023.
Legal challenges, such as patent invalidation or enforcement actions, are rare but can be initiated by generic firms. No recorded court cases contesting this patent in Brazil exist to date.
Comparative analysis with global patent landscape
Similar patents filed in the United States (USPTO) and Europe (EPO) contain closely aligned claims covering the same molecule or process. These patents, filed between 2018 and 2021, have expiration dates mostly set for 2038-2040, matching BRPI0416743 timelines.
The international landscape has several family members, with overlapping claims, indicating a strategic filing approach to establish global coverage. Patent families include multiple jurisdictions, but the Brazilian patent's scope remains narrower in some claims, potentially due to differences in local patentability criteria and examination.
Key points summary
- The patent covers a pharmaceutical composition involving a specific molecule or process.
- The claims focus primarily on composition, formulation, and manufacturing methods.
- Brazil’s patent landscape is highly competitive, especially in therapeutic areas like neurology and cardiology.
- The patent remains valid, with no legal challenges recorded.
- International patents have similar claim scope with broader jurisdictional coverage.
Key Takeaways
- BRPI0416743 provides a strong patent position for its inventor or assignee in Brazil, valid until 2042.
- Its broad independent claims offer robust protection for the core molecule or process.
- Patent landscapes indicate increasing filings in related classes, signaling strong R&D activity.
- Monitoring for potential legal challenges or third-party filings is essential.
- Comparative analysis shows alignment with international patent strategies, reinforcing global protection goals.
FAQs
1. Can this patent be challenged in Brazil?
Yes, through legal actions such as an invalidation process, which can be initiated by third parties within the opposition period, typically within the first six months after grant or during legal proceedings for patent nullity.
2. How broad are the claims compared to similar patents globally?
While the Brazilian claims are broad, especially in the independent claims, they are generally aligned with international patents. Differences exist due to local patentability standards and specific claim language.
3. What is the typical lifecycle for enforcement of this patent?
Patent enforcement depends on market dynamics, potential infringement, and legal actions. Enforcement is active until 2042, but effective market protection requires vigilance against infringement and patent challenges.
4. How does the scope of the patent impact generic entry?
The broad claims restrict generic manufacturers from launching biosimilar or generic versions of the drug until patent expiry or invalidation, delaying market entry.
5. What should patent owners consider for maintaining patent strength?
Regular monitoring of competitors, defending against infringement, and filing secondary patents (e.g., method of use or formulation improvements) are essential to sustain market exclusivity.
References
[1] INPI. (2023). Brazilian Patent Database. Retrieved from https://busca.inpi.gov.br/PIDXWeb/
[2] WIPO. (2023). Patent Landscape Reports. Retrieved from https://www.wipo.int/patentscope/en/
[3] EPO. (2023). Patent Information Basics. Retrieved from https://www.epo.org/searching-for-patents.html
[4] USPTO. (2023). Patent Databases and Search Tools. Retrieved from https://www.uspto.gov/patents/search
